Cleavage of the complement system C3 component by HIV-1 proteinase

Biological Chemistry

Volumn 378, Issue 5, 1997, Pages 439-442

  Kisselev, Alexei F ^a,b   Mentele, Reinhardt ^a   Von Der Helm, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

C3b inactivation; Complement C3; Complement system; HIV proteinase

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; PROTEINASE; VIRUS ENZYME;

ALPHA CHAIN; AMINO ACID SEQUENCE; ARTICLE; COMPLEMENT INHIBITION; CONTROLLED STUDY; ENZYME SUBSTRATE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMINO ACIDS; BINDING SITES; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3B; COMPLEMENT C3C; COMPLEMENT C3D; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIV PROTEASE; HUMANS; MOLECULAR WEIGHT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030993113     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Adams, L.D., Tomasselli, A.G., Robbins, P., Moss, B., and Heinrikson, R.L. (1992). HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res. Hum. Retroviruses. 8, 291-295.
2. Banapour B., Sernatinger, J., and Levy, J.A. (1986). The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 152, 268.
3. Boucher, C.A.B., de Jager, M.H., Debouck, C., Epstein, L.G., de Wolf, F., Wolfs, T.F.W., and Goudsmit, J. (1989). Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage. J. Clin. Microbiol. 27, 1577-1581.
4. Clare O'Keefe, M., Caporale, L.H., and Vogel, C.-W. (1988). A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol. Chem. 263, 12690-12697.
5. Dunn, B.M., Gustchina, A., Wlodawer, A., and Kay, J. (1994). Subsite preferences of retroviral proteinases. Meth. Enzymology 241, 254-278.
6. Ebenbichler, C.F., Thielens, N.M., Vornhagen, R., Marschang, P., Arlaud, G.J., and Dierich, M.P. (1991). Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174, 1417-1424.
7. Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Seidel, C.A., and Cines, D.B. (1984). Glycoprotein C of Herpes Simplex Virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309, 633.
8. Hammer, C.H., Wirtz, G.H., Renfer, L., Gresham, H.D., and Tack, B.F. (1981). Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256, 3995-4006.
9. Ho, D.D., Neumann, A.D., Perelson, A.S., Chen, W., Leonard, J.M., and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-127.
10. Janatova, J. (1988). C3, C5 components and C3a, C4a, and C5a fragments of the complement system. Meth. Enzymology 162, 579-625.
11. Kisselev, A.F., and von der Helm, K. (1994). Human immunodeficiency virus type 1 proteinase is rapidly and efficiently inactivated in human plasma by alpha-2 macroglobulin. Biol. Chem. 375, 711-714.
12. Kotwal, G. J., and Moss, B. (1988). Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-178.
13. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227, 680-685.
14. Lindhofer, H., Nitschko, H., Wachinger, G., and von der Helm, K. (1993). HIV PR in HIV-infected cell culture: dual intracellular effects in the absence or presence of inhibitor. In: Proteolysis and Protein Turnover, J.S. Bond and A.J. Barrett, eds. (London: Portland Press), pp. 219-224.
15. Marschang, P., Ebenbichler, C.F., and Dierich, M.P. (1994). HIV and complement: role of the complement system in HIV infection. Int. Arch. Allergy Immunol. 103, 113-117.
16. Mold, C., Bradt, B.M., Nemerow, G.R., and Cooper, N.R. (1988). Epstein-Barr virus regulates activation and processing of the third component of complement. J. Exp. Med. 168, 949.
17. Müller-Eberhard, H.J. (1988). Molecular organisation and function of the complement system. Ann. Rev. Biochem. 57, 321-347.
18. Oswald, M., and von der Helm, K. (1991). Fibronectin is a non-viral substrate for the HIV PR. FEBS Lett. 292, 298-300.
19. Pangburn, M. (1987). A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. J. Immunol. Meth. 102, 7-14.
20. Roberts, N.A., Martin, J.A., Kinchington, D., Broadhurst, A.V., Craig, J.C., Duncan, I.B., Galpin, S.A., Handa, B.K., Kay, J., Kröhn, A., Lambert, R.W., Merrett, J.H., Mills, J.S., Parkes, K.E.B., Redshaw, S., Ritchie, A.J., Taylor, D.L., Thomas, G.J., and Machin, P.J. (1990). Rational design of peptide-based HIV proteinase inhibitors. Science 248, 358-361.
21. Senaldi, G., Peakman, M., McManus, T., Davies, E.T., Tee, D.E.H., and Vergani, D. (1989). Classical complement pathway in HIV infection. Lancet II, No. 8663, 624.
22. Shoeman, R.L., Kesselmeier, C., Mothes, E., Hörner, B., and Traub, P. (1991). Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett. 278, 199-203.
23. Smith, G.L. (1994). Virus strategies for evasion of the host responce to infection. Trends Microbiol. 2, 81-88.
24. Sölder, B.M., Schulz, T.F., Hengster, P., Lower, J., Larcher, C., Bitterlich, G., Kurth, R., Wachter, H., and Dierich, M.P. (1989). HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol. Lett. 22, 135-146.
25. Strack, P.R., Frey, M.W., Rizzo, C.J., Cordova, B., George, H.J., Meade, R., Ho, S.P., Corman, J., Tritsch, R., and Korant, B. (1996). Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA. 93, 9571-9576.
26. Tomasselli, A.G., and Heinrikson, R.L. (1994). Specificity of retroviral proteinases: an analysis of viral and non-viral protein substrates, Meth. Enzymology 241, 279-301.
27. Tomasselli, A.G., Hui, J.O., Adams, L., Chosay, J., Lowery, D., Greenberg, B., Yem, A., Deibel, M.R., Zürher-Neely, H., and Heinrikson, R.L. (1991). Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1β as substrates of the protease from human immunodeficiency virus. J. Biol. Chem. 266, 14548-14553.
28. von der Helm, K., Seelmeir, S., Kisselev, A., and Nitschko, H. (1994). Identification, purification and cell-culture assays of retroviral proteases. Meth. Enzymology 241, 89-104.
29. Wallin, M., Deinum, J., Goobar, L., and Danielson, U.H. (1990). Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases. J. Gen. Virol. 71, 1985-1991.
30. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H., Saag, M.S., and Shaw, G.M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-123.